Rockwell Medical (RMTI) Form 144: RSU-Derived Insider Sale Disclosed

Rhea-AI Filing Summary

Rockwell Medical, Inc. (RMTI) filing a Form 144 reports a proposed sale of 2,868 common shares through Raymond James & Associates on 10/01/2025 on NASDAQ with an aggregate market value of 3,321.00. The filing shows the securities were acquired by the seller through RSU vesting on 03/15/2024 (10,010 shares) and 03/14/2025 (8,666 shares). The filer sold 2,868 shares on 07/01/2025 for gross proceeds of 2,271.00. The notice includes the standard attestation that the seller does not possess undisclosed material adverse information.

Positive

• Disclosure of RSU origin: the filing clearly states the shares were acquired via RSU vesting on 03/15/2024 and 03/14/2025.
• Timely regulatory notice: proposed sale and prior sale are disclosed consistent with Rule 144 requirements.
• Small relative size: 2,868 shares is immaterial compared with 34,430,352 shares outstanding.

Negative

• Insider sale: the person for whose account the sale is reported has sold and plans to sell shares, which could be perceived negatively by some investors.
• Limited detail: the filing contains no explanation of the reason for the sale beyond RSU origin and standard attestations.

Insights

Financial Analyst

TL;DR: Insider plans a small sale of vested RSUs; transaction size is immaterial versus total shares outstanding.

The filing indicates a planned sale of 2,868 common shares derived from RSU vesting, executed via a broker on a specified date. Compared with the reported 34,430,352 shares outstanding, this represents a de minimis portion of the public float and is unlikely to materially affect valuation or market liquidity. The prior sale on 07/01/2025 for 2,271.00 shows active disposition of vested awards. No financial performance metrics or additional corporate actions are disclosed.

Corporate Governance Expert

TL;DR: This is a routine insider disclosure showing RSU-derived sales and the customary attestation about material nonpublic information.

The document records that the securities originated from RSU vesting dates in 2024 and 2025 and that sales are being routed through Raymond James & Associates. The signer affirms compliance with disclosure requirements and the absence of undisclosed material adverse information. The filing contains required seller representations and a past sale record, aligning with Rule 144 procedural expectations. No governance actions or policy changes are reported.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	2868	3321.00	34430352	10/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2024	RSU Vesting	Issuer			10010	03/15/2024	RSU Vesting
Common	03/14/2025	RSU Vesting	Issuer			8666	03/14/2025	RSU Vesting

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Timothy Chole 10548 Starglow Ct Littleton CO 80126	Common	07/01/2025	2868	2271.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the RMTI Form 144 disclose about the number of shares to be sold?

The Form 144 reports a proposed sale of 2,868 common shares to be executed on 10/01/2025 through Raymond James & Associates.

How were the RMTI shares acquired that are being sold?

The shares were acquired through RSU vesting on 03/15/2024 (10,010 shares) and 03/14/2025 (8,666 shares).

Has the filer already sold any RMTI shares recently?

Yes; the filing records a sale by Timothy Chole of 2,868 shares on 07/01/2025 for gross proceeds of 2,271.00.

What is the aggregate market value and shares outstanding reported in the Form 144?

The aggregate market value for the proposed sale is reported as 3,321.00, and the number of shares outstanding is 34,430,352.

Does the filer state possession of any undisclosed material information about RMTI?

The filer signs the standard attestation representing that they do not know any material adverse information that has not been publicly disclosed.